Uncovering Oncologists' Gaps And Attitudes Toward Biosimilars: Impact Of A Two-Phase Educational Program.

91Background: Biosimilar agents are changing the clinical landscape in oncology. We sought to measure oncologists’ competence and knowledge of biosimilars and to address identified educational gaps related to biosimilars’ clinical application. Methods: We designed a 2-phase online educational program focused on biosimilars that included questions to measure oncologists’ knowledge and competence. These questions were administered before and then repeated after the education was delivered. Oncologists were also invited to submit their own questions about biosimilars and their use in clinical practice. To uncover key educational gaps, we identified questions with high incorrect responses at baseline, persistence of incorrect responses, and questions submitted by learners during Phase 1 of the education. These gaps were used to refine the teaching in Phase 2 of the education. Results: Between March and December 2017, a total of 1616 oncologists participated in the education. Among the subset of oncologists wh...